WO2017158366A3 - Dispositif d'administration ophtalmique et compositions médicamenteuses ophtalmiques - Google Patents

Dispositif d'administration ophtalmique et compositions médicamenteuses ophtalmiques Download PDF

Info

Publication number
WO2017158366A3
WO2017158366A3 PCT/GB2017/050731 GB2017050731W WO2017158366A3 WO 2017158366 A3 WO2017158366 A3 WO 2017158366A3 GB 2017050731 W GB2017050731 W GB 2017050731W WO 2017158366 A3 WO2017158366 A3 WO 2017158366A3
Authority
WO
WIPO (PCT)
Prior art keywords
ophthalmic
delivery device
drug compositions
space
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2017/050731
Other languages
English (en)
Other versions
WO2017158366A2 (fr
Inventor
Robert Steven Bley
Stanley R Conston
Ronald Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxular Ltd
Original Assignee
Oxular Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxular Ltd filed Critical Oxular Ltd
Priority to US16/085,106 priority Critical patent/US11622884B2/en
Priority to EP17713761.9A priority patent/EP3429519B1/fr
Priority to CN201780030729.5A priority patent/CN109640899B/zh
Priority to KR1020187028889A priority patent/KR102381775B1/ko
Priority to JP2018548417A priority patent/JP7209439B2/ja
Priority to AU2017235845A priority patent/AU2017235845B2/en
Priority to PL17713761.9T priority patent/PL3429519T3/pl
Priority to ES17713761T priority patent/ES2950350T3/es
Publication of WO2017158366A2 publication Critical patent/WO2017158366A2/fr
Publication of WO2017158366A3 publication Critical patent/WO2017158366A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5036—Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042—Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5052—Proteins, e.g. albumin
    • A61K9/5057—Gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/19—Syringes having more than one chamber
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/329—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles characterised by features of the needle shaft
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically
    • A61M2005/2026—Semi-automatic, e.g. user activated piston is assisted by additional source of energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/32—Needles; Details of needles pertaining to their connection with syringe or hub; Accessories for bringing the needle into, or holding the needle on, the body; Devices for protection of needles
    • A61M5/3205—Apparatus for removing or disposing of used needles or syringes, e.g. containers; Means for protection against accidental injuries from used needles
    • A61M5/321—Means for protection against accidental injuries by used needles
    • A61M5/3243—Means for protection against accidental injuries by used needles being axially-extensible, e.g. protective sleeves coaxially slidable on the syringe barrel
    • A61M5/326—Fully automatic sleeve extension, i.e. in which triggering of the sleeve does not require a deliberate action by the user
    • A61M2005/3267—Biased sleeves where the needle is uncovered by insertion of the needle into a patient's body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0612—Eyes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • A61M5/31598—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing having multiple telescopically sliding coaxial pistons encompassing volumes for components to be mixed
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/14—Type of nucleic acid interfering nucleic acids [NA]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Organic Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Anesthesiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physics & Mathematics (AREA)

Abstract

La présente invention concerne un dispositif de canulation pour l'administration d'une composition contenant un principe actif dans l'espace suprachoroïdien ou dans l'espace supraciiaire. L'invention concerne également des méthodes destinées à traiter une maladie ou une affection oculaire en conséquence. Des compositions destinées à être utilisées dans une méthode de traitement d'une maladie ou d'un état oculaire et à être administrée dans l'espace suprachoroïdien ou l'espace supraciliaire sont en outre décrites.
PCT/GB2017/050731 2016-03-16 2017-03-16 Dispositif d'administration ophtalmique et compositions médicamenteuses ophtalmiques Ceased WO2017158366A2 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
US16/085,106 US11622884B2 (en) 2016-03-16 2017-03-16 Ophthalmic delivery device and ophthalmic drug compositions
EP17713761.9A EP3429519B1 (fr) 2016-03-16 2017-03-16 Dispositif d'administration ophtalmique
CN201780030729.5A CN109640899B (zh) 2016-03-16 2017-03-16 眼科递送装置和眼科药物组合物
KR1020187028889A KR102381775B1 (ko) 2016-03-16 2017-03-16 안과용 전달 장치 및 안과용 약물 조성물
JP2018548417A JP7209439B2 (ja) 2016-03-16 2017-03-16 眼科用送達装置および眼科用薬物組成物
AU2017235845A AU2017235845B2 (en) 2016-03-16 2017-03-16 Ophthalmic delivery device and ophthalmic drug compositions
PL17713761.9T PL3429519T3 (pl) 2016-03-16 2017-03-16 Urządzenie do dostarczania oftalmicznego
ES17713761T ES2950350T3 (es) 2016-03-16 2017-03-16 Dispositivo de administración oftálmica

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662309350P 2016-03-16 2016-03-16
US62/309,350 2016-03-16

Publications (2)

Publication Number Publication Date
WO2017158366A2 WO2017158366A2 (fr) 2017-09-21
WO2017158366A3 true WO2017158366A3 (fr) 2017-11-30

Family

ID=58413141

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/GB2017/050731 Ceased WO2017158366A2 (fr) 2016-03-16 2017-03-16 Dispositif d'administration ophtalmique et compositions médicamenteuses ophtalmiques
PCT/GB2017/050730 Ceased WO2017158365A2 (fr) 2016-03-16 2017-03-16 Dispositif d'administration ophtalmique et compositions contenant un agent actif ophtalmique

Family Applications After (1)

Application Number Title Priority Date Filing Date
PCT/GB2017/050730 Ceased WO2017158365A2 (fr) 2016-03-16 2017-03-16 Dispositif d'administration ophtalmique et compositions contenant un agent actif ophtalmique

Country Status (10)

Country Link
US (2) US11622884B2 (fr)
EP (2) EP3429519B1 (fr)
JP (2) JP6946324B2 (fr)
KR (1) KR102381775B1 (fr)
CN (1) CN109640899B (fr)
AU (1) AU2017235845B2 (fr)
ES (1) ES2950350T3 (fr)
GB (3) GB2581866A (fr)
PL (1) PL3429519T3 (fr)
WO (2) WO2017158366A2 (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
WO2012051575A2 (fr) 2010-10-15 2012-04-19 Iscience Interventional Corporation Dispositif pour accès oculaire
SG10201702674PA (en) 2013-05-03 2017-06-29 Clearside Biomedical Inc Apparatus and methods for ocular injection
JP2019514581A (ja) 2016-05-02 2019-06-06 クリアサイド バイオメディカル，インコーポレイテッド 眼の薬物送達のためのシステムおよび方法
US10973681B2 (en) 2016-08-12 2021-04-13 Clearside Biomedical, Inc. Devices and methods for adjusting the insertion depth of a needle for medicament delivery
GB2568579B (en) * 2017-09-15 2022-06-29 Oxular Ltd Ophthalmic drug compositions
US11229722B2 (en) * 2018-01-29 2022-01-25 Omer Peled System and method for harvesting autologous adipose tissue
DE102018106217A1 (de) * 2018-03-16 2019-09-19 Amw Gmbh Applikator
CN111936093A (zh) * 2018-03-22 2020-11-13 阿尔法米德有限公司 泪小管内可溶解的泪小点塞插入器
AU2019316821B2 (en) * 2018-08-06 2025-05-08 Tomer BATASH Multi-lumen syringes for intraocular injections
WO2020157324A1 (fr) 2019-02-01 2020-08-06 Novo Nordisk A/S Dispositif médical ayant un mécanisme d'actionnement
EP3920950A1 (fr) 2019-02-08 2021-12-15 CureVac AG Arn codant administré dans l'espace suprachoroïdien pour le traitement de maladies ophtalmiques
EP4667578A3 (fr) 2019-04-03 2026-04-01 REGENXBIO Inc. Thérapie génique pour pathologies de l'oeil
PE20240329A1 (es) 2019-06-05 2024-02-27 Regeneron Pharma Dispositivos y metodos para administracion de dosis de precision
EP3980110A1 (fr) * 2019-06-07 2022-04-13 Novo Nordisk A/S Dispositif ingérable avec détachement d'élément de distribution
EP4061452B1 (fr) * 2019-11-21 2026-06-24 Altaviz, LLC Canule à pointe souple avec protecteur de pointe rétractable
WO2021140419A1 (fr) * 2020-01-08 2021-07-15 Azura Ophthalmics Ltd. Dispositif d'administration d'un médicament à une paupière
WO2021252841A1 (fr) * 2020-06-11 2021-12-16 Aescula Tech, Inc. Dispositif d'injection contrôlée pour différentes propriétés de matériau
JP2023544803A (ja) 2020-10-07 2023-10-25 レジェンクスバイオ インコーポレーテッド Ｃｌｎ２疾患の眼症状に対する遺伝子療法
CN112933380B (zh) * 2021-02-01 2023-01-20 温州市中西医结合医院 一种双重肛肠给药装置
MX2023012212A (es) * 2021-04-16 2023-10-26 Aerie Pharmaceuticals Inc Dispositivo de suministro de implante.
CN115337083B (zh) * 2021-05-13 2025-01-10 中国医学科学院北京协和医院 医疗器具总成
US12649031B2 (en) 2021-09-08 2026-06-09 Regeneron Pharmaceuticals, Inc. Methods for delivering agents with pre-filled syringes to minimize intraocular inflammation
AU2022356475A1 (en) * 2021-09-30 2024-02-22 Alcon Inc. Apparatus for subretinal injection
USD1037439S1 (en) 2022-01-17 2024-07-30 EyePoint Pharamaceuticals, Inc. Ocular injector
EP4489702A4 (fr) * 2022-03-07 2025-09-03 Univ Johns Hopkins Procédé et système d'administration d'agents thérapeutiques à l'oeil
US20250249127A1 (en) 2022-04-14 2025-08-07 Regenxbio Inc. Gene therapy for treating an ocular disease
EP4593955A1 (fr) 2022-09-30 2025-08-06 RegenxBio Inc. Traitement de maladies oculaires avec des vecteurs viraux recombinés codant un fab anti-vegf
CN115814246B (zh) * 2022-11-10 2025-12-09 卡尤迪生物科技宜兴有限公司 递送装置及递送方法
USD1120314S1 (en) 2022-11-30 2026-03-24 Regeneron Pharmaceuticals, Inc. Dose delivery device
IL322812A (en) * 2023-02-17 2025-10-01 Amir Avraham Microneedle for intradermal filler
JP2026520892A (ja) * 2023-06-22 2026-06-25 アルコン インコーポレイティド 網膜下送達のための方法及び装置
CN122161565A (zh) * 2023-11-08 2026-06-05 里珍纳龙药品有限公司 用于眼部组织的药物递送的系统及方法
US20250360272A1 (en) * 2024-05-21 2025-11-27 Becton, Dickinson And Company Injection device with stabilizing passive needle shield
US20260130795A1 (en) 2024-11-12 2026-05-14 Regeneron Pharmaceuticals, Inc. Systems and methods for drug delivery to ocular tissue

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089409A2 (fr) * 2008-01-10 2009-07-16 Bausch & Lomb Incorporated Système d'injection intravitréen à canules coaxiales et son utilisation
US20110238075A1 (en) * 2009-12-23 2011-09-29 Luke Clauson Drug delivery devices and methods
WO2013028936A1 (fr) * 2011-08-23 2013-02-28 Itech Jv Development Company, Llc Systèmes et procédés pour faire une injection
WO2013151904A1 (fr) * 2012-04-02 2013-10-10 Ocuject, Llc Dispositifs d'administration intraoculaire et procédés associés
WO2016042163A2 (fr) * 2014-09-19 2016-03-24 Medterials, Inc. Compositions médicamenteuses ophtalmiques

Family Cites Families (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1641976A (en) 1926-08-21 1927-09-13 Antoine A Laurent Hypodermic syringe
US3890971A (en) 1973-10-23 1975-06-24 Thomas A Leeson Safety syringe
US5078697A (en) * 1990-11-28 1992-01-07 Rammler David H Syringe needle guard
US5102388A (en) * 1991-07-15 1992-04-07 Richmond John E Sequential delivery syringe
US5236424A (en) * 1992-06-05 1993-08-17 Cardiac Pathways Corporation Catheter with retractable cannula for delivering a plurality of chemicals
US5295972A (en) 1992-08-04 1994-03-22 Metatech Corporation Hypodermic syringe with protective cap
US5250031A (en) * 1992-12-14 1993-10-05 The George Washington University Locking needle cover
US5540664A (en) * 1993-05-27 1996-07-30 Washington Biotech Corporation Reloadable automatic or manual emergency injection system
US5358489A (en) * 1993-05-27 1994-10-25 Washington Biotech Corporation Reloadable automatic or manual emergency injection system
GB9412301D0 (en) 1994-06-17 1994-08-10 Safe T Ltd Hollow-needle drugs etc applicators
DE69505407T2 (de) 1994-08-24 1999-05-27 Westinghouse Electric Corp., Pittsburgh, Pa. Gasturbinenschaufel mit gekühlter plattform
US6916000B2 (en) 1998-07-02 2005-07-12 Jeffrey N. Weiss Apparatus and method for cannulating retinal blood vessels
US6409706B1 (en) * 1999-05-14 2002-06-25 Randall A. Loy Safety syringe, fluid collection device, and associated methods
US6551291B1 (en) * 1999-08-04 2003-04-22 Johns Hopkins University Non-traumatic infusion cannula and treatment methods using same
AU2001290782A1 (en) 2001-09-13 2003-03-24 Weiss, Jeffrey, N. Apparatus and method for cannulating retinal blood vessels
US6972008B2 (en) 2002-10-21 2005-12-06 Ultradent Products, Inc. Syringe having a tapered plunger
US20040039337A1 (en) 2002-08-21 2004-02-26 Letzing Michael Alexander Portable safety auto-injector
US7530968B2 (en) 2003-04-23 2009-05-12 Valeritas, Inc. Hydraulically actuated pump for long duration medicament administration
US7824373B2 (en) 2003-05-28 2010-11-02 Ducksoo Kim Self-contained power-assisted syringe
US20050027255A1 (en) * 2003-07-31 2005-02-03 Sid Technologies, Llc Automatic injector
US20060141049A1 (en) * 2003-11-12 2006-06-29 Allergan, Inc. Triamcinolone compositions for intravitreal administration to treat ocular conditions
US20090148527A1 (en) 2007-12-07 2009-06-11 Robinson Michael R Intraocular formulation
EP2248494B1 (fr) 2004-01-23 2013-06-05 iScience Interventional Corporation Microcanule ophtalmique composite
KR20110139772A (ko) 2004-04-29 2011-12-29 아이싸이언스 인터벤셔날 코포레이션 안과 치료를 위한 장치와 방법
US7226435B2 (en) 2004-10-14 2007-06-05 Alcon, Inc. Drug delivery device
US20070202186A1 (en) 2006-02-22 2007-08-30 Iscience Interventional Corporation Apparatus and formulations for suprachoroidal drug delivery
US9039761B2 (en) * 2006-08-04 2015-05-26 Allergan, Inc. Ocular implant delivery assemblies with distal caps
US8251960B2 (en) 2007-03-24 2012-08-28 The Alfred E. Mann Foundation For Scientific Research Valves, valved fluid transfer devices and ambulatory infusion devices including the same
CN101754778B (zh) * 2007-07-19 2012-04-18 Shl集团有限责任公司 用于传送药物的自动装置
US20090036827A1 (en) 2007-07-31 2009-02-05 Karl Cazzini Juxtascleral Drug Delivery and Ocular Implant System
US8353862B2 (en) 2007-11-02 2013-01-15 Allergan, Inc. Drug delivery systems and methods
US8945086B2 (en) 2008-07-01 2015-02-03 Bruce Becker Retrobulbar needle and methods of use
JP4918530B2 (ja) * 2008-07-30 2012-04-18 日東電工株式会社 光学フィルム積層体の製造方法
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
US20100104654A1 (en) 2008-10-27 2010-04-29 Allergan, Inc. Prostaglandin and prostamide drug delivery systems and intraocular therapeutic uses thereof
EP2424556A4 (fr) 2009-04-27 2013-07-31 Jerini Ophthalmic Inc Formulations à libération prolongée de médicament peptidomimétique et leurs utilisations
EP3184136B1 (fr) 2010-03-25 2021-06-02 New Injection Systems Ltd Injecteur
DE102010048085A1 (de) 2010-10-04 2012-04-05 Ing. Erich Pfeiffer Gmbh Austragvorrichtung
WO2012051575A2 (fr) * 2010-10-15 2012-04-19 Iscience Interventional Corporation Dispositif pour accès oculaire
JP5968325B2 (ja) * 2010-11-03 2016-08-10 サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング 薬物の漏出防止のための方法及びシステム
US20120215183A1 (en) 2011-02-22 2012-08-23 Medtronic Minimed, Inc. Fluid infusion device having a sealing assembly for a fluid reservoir
US8432441B2 (en) 2011-02-22 2013-04-30 Hermes Microvision Inc. Method and system for measuring critical dimension and monitoring fabrication uniformity
US9095412B2 (en) * 2012-03-20 2015-08-04 Sight Sciences, Inc. Ocular delivery systems and methods
SG11201408220XA (en) 2012-06-12 2015-01-29 Altaviz Llc Intraocular gas injector
JP6647043B2 (ja) * 2012-10-25 2020-02-14 ノボ・ノルデイスク・エー／エス 充填済みの使い捨て注射装置
US20140257200A1 (en) * 2013-03-11 2014-09-11 Judith Auerbach Safety system for a needle retaining device
US9414990B2 (en) * 2013-03-15 2016-08-16 Becton Dickinson and Company Ltd. Seal system for cannula
SG10201702674PA (en) 2013-05-03 2017-06-29 Clearside Biomedical Inc Apparatus and methods for ocular injection
JP6548229B2 (ja) * 2014-02-12 2019-07-24 オービット・バイオメディカル・リミテッドＯｒｂｉｔ Ｂｉｏｍｅｄｉｃａｌ Ｌｉｍｉｔｅｄ 治療薬の脈絡膜上投与のための方法及び装置
US9949874B2 (en) * 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
US10064752B2 (en) 2014-09-11 2018-09-04 Orbit Biomedical Limited Motorized suprachoroidal injection of therapeutic agent
AU2015316709B2 (en) * 2014-09-19 2020-03-26 Oxular Limited Ophthalmic delivery device
CA2980713C (fr) 2015-03-31 2023-10-03 Sight Sciences, Inc. Systemes et procedes de pose oculaire
CN106492284B (zh) 2016-11-18 2018-10-02 李世荣 一种生物可降解充填材料的制备方法及其产品和应用

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009089409A2 (fr) * 2008-01-10 2009-07-16 Bausch & Lomb Incorporated Système d'injection intravitréen à canules coaxiales et son utilisation
US20110238075A1 (en) * 2009-12-23 2011-09-29 Luke Clauson Drug delivery devices and methods
WO2013028936A1 (fr) * 2011-08-23 2013-02-28 Itech Jv Development Company, Llc Systèmes et procédés pour faire une injection
WO2013151904A1 (fr) * 2012-04-02 2013-10-10 Ocuject, Llc Dispositifs d'administration intraoculaire et procédés associés
WO2016042163A2 (fr) * 2014-09-19 2016-03-24 Medterials, Inc. Compositions médicamenteuses ophtalmiques

Also Published As

Publication number Publication date
WO2017158365A3 (fr) 2017-11-30
JP7209439B2 (ja) 2023-01-20
KR20190014496A (ko) 2019-02-12
GB201704205D0 (en) 2017-05-03
GB2581866A (en) 2020-09-02
GB2548988A (en) 2017-10-04
AU2017235845B2 (en) 2022-06-09
PL3429519T3 (pl) 2023-10-30
EP3429518A2 (fr) 2019-01-23
CN109640899A (zh) 2019-04-16
JP2019515705A (ja) 2019-06-13
ES2950350T3 (es) 2023-10-09
GB201913962D0 (en) 2019-11-13
WO2017158365A2 (fr) 2017-09-21
CN109640899B (zh) 2022-04-08
JP6946324B2 (ja) 2021-10-06
KR102381775B1 (ko) 2022-04-04
AU2017235845A1 (en) 2018-10-18
EP3429518B1 (fr) 2023-04-26
JP2019509122A (ja) 2019-04-04
GB201704211D0 (en) 2017-05-03
US20210169689A1 (en) 2021-06-10
GB2548987B (en) 2019-04-24
EP3429519A2 (fr) 2019-01-23
GB2548988B (en) 2019-11-13
US11622884B2 (en) 2023-04-11
GB2548987A (en) 2017-10-04
WO2017158366A2 (fr) 2017-09-21
US20200330269A1 (en) 2020-10-22
EP3429519B1 (fr) 2023-04-26

Similar Documents

Publication Publication Date Title
WO2017158365A3 (fr) Dispositif d'administration ophtalmique et compositions contenant un agent actif ophtalmique
EP4566651A3 (fr) Dispositif d'administration ophtalmique
WO2016042163A3 (fr) Compositions médicamenteuses ophtalmiques
WO2018115097A9 (fr) Composition ophtalmologique pour le traitement du syndrome de l'oeil sec
WO2015095772A3 (fr) Préparations et procédés servant à introduire de manière ciblée des agents thérapeutiques dans l'œil
EA201991299A1 (ru) Приготовление твердых циклодекстриновых комплексов для доставки офтальмологических активных фармацевтических ингредиентов
MX378707B (es) Compuestos para el tratamiento de enfermedades y trastornos oftalmicos.
IL273531A (en) Ophthalmic preparations containing latanoprost for use in the treatment of eye diseases
MX2024007658A (es) Composiciones y metodos de uso de nintedanib para mejorar el exito de la cirugia del glaucoma.
BR112014008789A2 (pt) prevenção e tratamento de condições oculares
MX2020006309A (es) Fórmulaciones de parasiticida de isoxazolina y métodos para el tratamiento de la blefaritis.
MX2019013799A (es) Peptido novedoso y composicion farmaceutica para tratar una enfermedad ocular que comprende el mismo como un ingrediente farmaceutico activo.
WO2016191458A3 (fr) Compositions pharmaceutiques ayant un effet sur l'état d'oxydoréduction mitochondriale et méthodes de traitement associées
MX2016015211A (es) Formulaciones topicas y usos de las mismas.
WO2018234871A3 (fr) Compositions pour administration de médicaments et leurs procédés d'utilisation
EA202191684A1 (ru) Средство, содержащее урсодезоксихолевую кислоту, для лечения или профилактики пресбиопии
WO2016011297A3 (fr) Procédés et compositions associées permettant d'améliorer la biodisponibilité des médicaments pour un meilleur traitement des maladies
WO2015048188A3 (fr) Facteurs de croissance des fibroblastes modifiés pour le traitement de troubles oculaires
WO2014161004A3 (fr) Compositions et procédés pour l'administration de médicaments à la surface oculaire par des lentilles de contact
MA56220A (fr) Formulations oculaires permettant l'administration de médicament et la protection du segment antérieur de l'oeil
WO2013189606A3 (fr) Thérapie intermittente pour le traitement de la perte de la vision chez des êtres humains ayant un glaucome et d'autres maladies dégénératives de l'œil
WO2018005794A3 (fr) Nouveaux agonistes de tgr5 non systémiques
HK1255114A1 (zh) 抗真菌剂
CL2020001426A1 (es) Composición tópica oftálmica que comprende ácido dobesilico para tratar enfermedades del segmento posterior del ojo.
WO2015094019A3 (fr) Composition pharmaceutique destinée à la prévention et au traitement de la myopie pernicieuse

Legal Events

Date Code Title Description
ENP Entry into the national phase

Ref document number: 2018548417

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 20187028889

Country of ref document: KR

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 2017713761

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2017235845

Country of ref document: AU

Date of ref document: 20170316

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2017713761

Country of ref document: EP

Effective date: 20181016

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17713761

Country of ref document: EP

Kind code of ref document: A2